Landiao, Cherilyn S.
HRN: 17-58-09 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/05/2024
METRONIDAZOLE 500MG (TAB)
03/05/2024
03/11/2024
ORAL
500mg
TID
T/C Amoebic Dysentery
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes